logo-loader
RNS
Falanx Group Ltd

Falanx Group Limited - Issue of Equity and TVR

RNS Number : 2142U
Falanx Group Limited
01 April 2021
 

 

1 April 2021 

FALANX GROUP LIMITED

("Falanx", the "Group" or the "Company")

Issue of Equity and TVR

 

Falanx Group Limited (AIM: FLX), the AIM listed provider of cyber security and strategic intelligence services, announces that, on 31 March 2021, 600,000 options over Depositary Interests in respect of ordinary shares of nil par value (the "Ordinary Shares") in the share capital of the Company were exercised by certain non PDMR option holders of the Company.

 

Application has been made to the London Stock Exchange for the 600,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence at 8.00 a.m. on or around 9 April 2021. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

 

The total number of Ordinary Shares in issue following Admission will be 526,001,185. There are no Ordinary Shares held in treasury. The total number of voting rights in the Company is therefore 526,001,185. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh / Luisa Orsini Baroni

+ 44 (0) 207 710 7600

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

 

+44 (0) 203 934 663

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: https://www.falanx.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDAFAFEFSELD
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read